Aurinia Pharmaceuticals Inc (AUPH) Revenue by Year

AUPH

Aurinia Pharmaceuticals Inc generated $283.1M in revenue in fiscal year 2025. This represents an increase of 20.4% from the prior fiscal year. Over the trailing 12 months, Q3 FY2025 through Q2 FY2026, the same line adds up to $311.5M in revenue. The table below carries 8 fiscal years, from 2018 to 2025, and the quarters Aurinia Pharmaceuticals Inc has filed alongside them.

FY2025 annual

Revenue $283.1M

YoY +20.4%

5Y CAGR +41.4%

Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Aug 6, 2026 Currency USD

Annual figures, oldest first. Point at a bar to read its period.

AUPH Revenue by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K
Revenue	$311.5M	$283.1M+20.4%	$235.1M+34.0%	$175.5M+31.0%	$134.0M+193.9%	$45.6M-9.0%	$50.1M+15660.4%	$318K-31.3%	$463K

TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.

AUPH Revenue by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-K	Q3'2510-K	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-K	Q2'2410-K	Q1'2410-K	Q4'2310-K	Q3'2310-K
Revenue	$83.2M+18.9%	$77.7M+24.4%	$77.1M+28.8%	$73.5M+8.4%	$70.0M+22.4%	$62.5M+24.2%	$59.9M+32.8%	$67.8M+24.3%	$57.2M+37.8%	$50.3M+46.2%	$45.1M+58.6%	$54.5M-2.3%

What revenue means

Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it.

More Aurinia Pharmaceuticals Inc financials

Frequently Asked Questions

What was Aurinia Pharmaceuticals Inc's revenue in fiscal year 2025?

Aurinia Pharmaceuticals Inc generated $283.1M in revenue in fiscal year 2025.

How fast is Aurinia Pharmaceuticals Inc's revenue growing?

Aurinia Pharmaceuticals Inc (AUPH) revenue rose by 20.4% year over year, from $235.1M to $283.1M in fiscal year 2025.

What is Aurinia Pharmaceuticals Inc's revenue over the last twelve months?

Aurinia Pharmaceuticals Inc (AUPH) reported $311.5M in revenue over the trailing 12 months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.

How has Aurinia Pharmaceuticals Inc's revenue changed over the years?

Across the 8 fiscal years this page covers, Aurinia Pharmaceuticals Inc (AUPH) revenue went from $463K in fiscal year 2018 to $283.1M in fiscal year 2025.

What was Aurinia Pharmaceuticals Inc's revenue in the most recent quarter?

Aurinia Pharmaceuticals Inc (AUPH) reported $83.2M in revenue in Q2 2026. This represents an increase of 18.9% from the same quarter a year earlier.

What does revenue mean on a financial statement?

Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it. This page lists what Aurinia Pharmaceuticals Inc (AUPH) reported on that line in every period on record.